Gritstone bio to Participate in Upcoming Investor Conferences

On September 5, 2023 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported that management will be participating in the following investor conferences (Press release, Gritstone Bio, SEP 5, 2023, View Source [SID1234634891]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Wells Fargo Healthcare Conference (1x1s only)
Conference Dates: September 6 – 8, 2023
Location: Boston, MA

H.C. Wainwright 25th Annual Global Investment Conference (Fireside Chat)
Presentation Date and Time: Wednesday, September 13, 2023 at 11:30am ET
Speaker: Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer
Location: New York, NY
Webcast: View Source

Cantor Global Healthcare Conference (Fireside Chat)
Presentation Date and Time: Thursday, September 28, 2023 at 2:25pm ET
Speaker: Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer
Location: New York, NY
Webcast: View Source

JonesTrading 2023 Healthcare Summit (1x1s only)
Conference Dates: October 9 – 11, 2023
Location: Miami, FL

BIO Investor Forum (Panel Participation)
Panel Title: Extending RNA Technology Pipelines into New Tissues and Applications​
Panel Date and Time: Tuesday, October 17, 2023 from 3:00 to 3:50pm PT
Speaker: Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer
Location: San Francisco, CA

The live webcasts will also be available via View Source Archived replays will be accessible for 30 days following the event.